Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
01/07/2019	14h30	Business Wire	Teva Announces Launch of 1% Sodium Hyaluronate in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
19/06/2019	19h00	Business Wire	Teva Announces Launch of a Generic Version of Tracleer® (bosentan) Tablets in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/06/2019	09h27	Dow Jones News	Shield Therapeutics Faces Appeal from Teva over Ferracru Patent	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
29/05/2019	20h30	Dow Jones News	Johnson & Johnson Weighs on Pharmaceutical ETFs	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
29/05/2019	08h00	Business Wire	Teva to present new fremanezumab FOCUS Clinical Study Data for the first time at the 13th European Headache Federation Congress	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/05/2019	18h45	Business Wire	Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) Extended-Release Tablets in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/05/2019	18h23	Dow Jones News	Opioid Suits May Reduce Appetite for Pharma Companies -- ESG Insight	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/05/2019	14h29	Dow Jones News	First Big Trial in Opioid Crisis Set to Kick Off in Oklahoma	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
26/05/2019	18h50	Dow Jones News	Teva Settles Oklahoma Opioid Case for $85 Million -- Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
26/05/2019	18h39	Dow Jones News	Teva Settles Oklahoma Opioid Case for $85 Million	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
26/05/2019	16h30	Business Wire	Company Statement: Teva Reaches Agreement with State of Oklahoma to Resolve State’s Claims Against the Company	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/05/2019	17h51	Business Wire	Teva Announces the Launch of a Generic Version of Delzicol® (mesalamine) Delayed-Release Capsules in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/05/2019	23h31	Dow Jones News	Teva Launches Generic Version of Tarceva in US	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/05/2019	22h06	Business Wire	Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/05/2019	14h00	Business Wire	Teva to Present New Long-Term Data on Efficacy and Safety of Fremanezumab at 2019 American Academy of Neurology Annual Meeting	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
02/05/2019	13h00	Business Wire	Teva Reports First Quarter 2019 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/05/2019	21h01	Business Wire	Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/05/2019	14h00	Business Wire	Teva to Present New Central Nervous System Portfolio Data at 71st Annual Meeting of the American Academy of Neurology	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/05/2019	02h28	Dow Jones News	Whistleblower Challenges SEC Over Delay on Award Decision	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/04/2019	17h10	Dow Jones News	Teva Ends Development of Fremanezumab in Cluster Headache	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/04/2019	15h00	Business Wire	Teva Announces Update on Fremanezumab Clinical Development for use in Episodic Cluster Headache	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/04/2019	17h03	Business Wire	Teva Announces Launch of a Generic Version of VESIcare® (solifenacin succinate) Tablets in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
19/04/2019	18h07	Dow Jones News	Teva Pharma Gets FDA Approval to Market Generic Nasal Spray for Opioid Overdoses	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/04/2019	16h00	Business Wire	Teva Announces Launch of a Generic Version of AndroGel® (testosterone gel) 1.62% CIII in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/04/2019	14h00	Business Wire	Teva Signs New $2.3 Billion Syndicated Revolving Credit Facility	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/04/2019	23h00	Business Wire	Teva to Host Conference Call to Discuss First Quarter 2019 Financial Results at 8 a.m. ET on May 2, 2019	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
05/04/2019	18h25	Dow Jones News	Oklahoma Attorney General Dismisses Some Claims Against Opioid Makers -- Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
05/04/2019	14h44	Dow Jones News	Oklahoma Attorney General Dismisses Some Claims Against Opioid Makers	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/04/2019	14h08	Business Wire	Teva’s AJOVY® Receives EU Approval Offering Patients the First & Only Anti-CGRP Treatment with Both Quarterly & Monthly Do...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/04/2019	09h00	Business Wire	Teva’s COPAXONE® 40mg – Favorable Response from European Patent Office	NYSE:TEVA	Teva Pharmaceutical Industries Ltd

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Suivant >>

Credit Agricole

Lvmh Moet Hennessy Louis...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales